Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies

By Cui Dandan   Cao Dan   Yang Yu   Qiu Meng   Huang Ying   Yi Cheng  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1291-1298

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal antibodies therapies for ovarian cancer

By Leone Roberti Maggiore Umberto   Bellati Filippo   Ruscito Ilary   Gasparri Maria Luisa   Alessandri Franco   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 739-764

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies for brain tumour treatment

By Boskovitz Abraham   Wikstrand Carol J   Kuan Chien-Tsun   Zalutsky Michael R   Reardon David A   Bigner Darell D  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1453-1471

Informa Healthcare

Access to resources Recommend Favorite

BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis

By Mao Chen   Liao Ru-Yan   Qiu Li-Xin   Wang Xi-Wen   Ding Hong   Chen Qing  

Molecular Biology Reports, Vol. 38, Iss. 4, 2011-04 ,pp. : 2219-2223

Springer Publishing Company

Access to resources Recommend Favorite

Applications of monoclonal antibodies for the treatment of hematological malignancies

By Migkou Magda   Dimopoulos Meletios-Athanassios   Gavriatopoulou Maria   Terpos Evangelos  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 207-220

Informa Healthcare

Access to resources Recommend Favorite